Bid opportunityOpen

HSLN CMOS Camera System

COMMERCE, DEPARTMENT OF › NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY › DEPT OF COMMERCE NIST

Response deadlineAug 19, 2026 11:00 AM EDT

Verify before acting. Users must verify deadlines, amendments, attachments, eligibility, and submission requirements on the official SAM.gov notice. Read the Data Disclaimer.

Key decision factors

Response deadline: Aug 19, 2026 11:00 AM EDT
Posted: Aug 9, 2026 12:00 AM EDT
Notice type: Combined Synopsis/Solicitation
Set-aside: Not provided or not applicable
NAICS: 334516
PSC: 6640
Place of performance: Gaithersburg, Maryland
Current status: Open

Notice details

Official status: Open
Normalized group: Bid opportunity
Notice ID: 81c38fb81ab54bbeb7c0bb1b492ea9c1
Solicitation number: 1333ND26QNB640412

Description

Displayed as sanitized plain text from SAM.gov. Retrieved Aug 15, 2026 8:02 PM EDT.

The gene therapy manufacturing innovations in measurement sciences (IMS) project, in the Biosystems and Biomaterials Division, Material Measurement Laboratory, National Institute of Standards and Technology, aims to develop light scattering microscopy methods to characterize gene delivery particles. Emerging gene therapy treatments use gene delivery nanoparticles, such as viral vectors and non-viral carriers, to cure intractable diseases. These manufactured particles suffer heterogeneity issues that hinder treatment efficacy and safety. This project aims to develop light-scattering microscopy methods to enable rapid, multi-attribute measurements of individual gene therapy nanoparticles’ physical characteristics, speeding the development of new treatments and improving their efficacy and safety.

Attachments

3 attachments reported by SAM.gov

Files are hosted by SAM.gov. Open the official notice to review and download them.

View attachments on SAM.gov (opens in a new tab)

Contacts

Rene D. Edwards

Primary

rene.edwards@nist.gov

Phone: 3019756107

Robert Singman

Secondary

robert.singman@nist.gov

Phone: 3019756388

Personalized relevance

Would this fit your company?

Create company profile information with a free account to see a deterministic, explainable relevance score. Matching does not determine eligibility or win probability.

Create Free Account

Pursuit risk (separate from your match score)

Document analysis pending

Some solicitation documents have not been analyzed yet. Additional restrictions may still be present.

Pursuit risk is evaluated separately from your match score above and never changes it. This is not a legal or eligibility determination — verify against the official SAM.gov notice and attachments.